FBR Capital Maintains an 'Underperform' on Gentiva Health Services (GTIV); Stimulating Volume Growth in Odyssey and Home Health Is Next Challenge
Tweet Send to a Friend
FBR Capital maintains an 'Underperform' rating on Gentiva Health Services (NASDAQ: GTIV), PT $21.
FBR analyst says, "Gentiva is in ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
FBR analyst says, "Gentiva is in ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
